United Health Products, Inc. (UEEC) stock
UEECOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.04−0.01 (-23.53%)
Close on Oct 19, 2026Market cap $10.25MP/E –Yield –
United Health Products operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
United Health Products's operating income for the twelve months ending Sep 30, 2026 was -$829.64K. For fiscal 2025 it was -$2.26M. The highest annual figure on record is -$207.02K in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.26M | – |
| FY2024 | Dec 31, 2024 | -$2.01M | – |
| FY2023 | Dec 31, 2023 | -$2.43M | – |
| FY2022 | Dec 31, 2022 | -$2.80M | – |
| FY2021 | Dec 31, 2021 | -$29.80M | – |
| FY2020 | Dec 31, 2020 | -$14.85M | – |
| FY2019 | Dec 31, 2019 | -$6.09M | – |
| FY2018 | Dec 31, 2018 | -$1.90M | – |
| FY2017 | Dec 31, 2017 | -$928.42K | – |
| FY2016 | Dec 31, 2016 | -$517.48K | – |
| FY2015 | Dec 31, 2015 | -$2.58M | – |
| FY2014 | Dec 31, 2014 | -$2.09M | – |
| FY2013 | Dec 31, 2013 | -$1.32M | – |
| FY2012 | Dec 31, 2012 | -$207.02K | – |
| FY2011 | Dec 31, 2011 | -$1.32M | – |
| FY2010 | Dec 31, 2010 | -$2.63M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$150.82K | – |
| Q2 FY2026 | Jun 30, 2026 | -$166.85K | – |
| Q1 FY2026 | Mar 31, 2026 | -$265.58K | – |
| Q4 FY2025 | Dec 31, 2025 | -$246.39K | – |
| Q3 FY2025 | Sep 30, 2025 | -$244.04K | – |
| Q2 FY2025 | Jun 30, 2025 | -$268.36K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.49M | – |
| Q4 FY2024 | Dec 31, 2024 | -$785.40K | – |
| Q3 FY2024 | Sep 30, 2024 | -$391.90K | – |
| Q2 FY2024 | Jun 30, 2024 | -$405.18K | – |
| Q1 FY2024 | Mar 31, 2024 | -$425.09K | – |
| Q4 FY2023 | Dec 31, 2023 | -$446.66K | – |
| Q3 FY2023 | Sep 30, 2023 | -$450.45K | – |
| Q2 FY2023 | Jun 30, 2023 | -$475.46K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$553.56K | – |
| Q3 FY2022 | Sep 30, 2022 | -$539.18K | – |
| Q2 FY2022 | Jun 30, 2022 | -$754.80K | – |
| Q1 FY2022 | Mar 31, 2022 | -$954.50K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.07M | – |
| Q3 FY2021 | Sep 30, 2021 | -$724.42K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.30M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.71M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.11M | – |
| Q2 FY2020 | Jun 30, 2020 | -$647.88K | – |
| Q1 FY2020 | Mar 31, 2020 | -$623.81K | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.35M | – |
| Q3 FY2019 | Sep 30, 2019 | -$478.72K | – |
| Q2 FY2019 | Jun 30, 2019 | -$604.33K | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.66M | – |
| Q4 FY2018 | Dec 31, 2018 | -$223.21K | – |
| Q3 FY2018 | Sep 30, 2018 | -$397.79K | – |
| Q2 FY2018 | Jun 30, 2018 | -$918.43K | – |
| Q1 FY2018 | Mar 31, 2018 | -$357.54K | -676.7% |
| Q4 FY2017 | Dec 31, 2017 | -$746.13K | – |
| Q3 FY2017 | Sep 30, 2017 | -$135.51K | – |
| Q2 FY2017 | Jun 30, 2017 | -$108.77K | – |
| Q1 FY2017 | Mar 31, 2017 | $61.99K | – |
| Q4 FY2016 | Dec 31, 2016 | -$176.42K | – |
See a number that looks wrong?